Mihara K - Search Results

1

[Neoadjuvant chemotherapy for advanced epithelial ovarian cancer].

Hatae M, Onishi Y, Nakamura T, Yamamoto H, Kusumoto M, Matsui T, Mihara K, Taniguchi H. Hatae M, et al. Among authors: mihara k. Gan To Kagaku Ryoho. 2001 Nov;28(12):1833-7. Gan To Kagaku Ryoho. 2001. PMID: 11729475 Review. Japanese.

2

Prenatal diagnosis and management of vasa previa: a 6-year review.

Kanda E, Matsuda Y, Kamitomo M, Maeda T, Mihara K, Hatae M. Kanda E, et al. Among authors: mihara k. J Obstet Gynaecol Res. 2011 Oct;37(10):1391-6. doi: 10.1111/j.1447-0756.2011.01544.x. Epub 2011 May 22. J Obstet Gynaecol Res. 2011. PMID: 21599804

3

High proportions of VLA-5- immature myeloma cells correlated well with poor response to treatment in multiple myeloma.

Kawano MM, Mahmoud MS, Huang N, Lisukov IA, Mihara K, Tsujimoto T, Kuramoto A. Kawano MM, et al. Among authors: mihara k. Br J Haematol. 1995 Dec;91(4):860-4. doi: 10.1111/j.1365-2141.1995.tb05401.x. Br J Haematol. 1995. PMID: 8547130

4

Expression of CD21 antigen on myeloma cells and its involvement in their adhesion to bone marrow stromal cells.

Huang N, Kawano MM, Mahmoud MS, Mihara K, Tsujimoto T, Niwa O, Kuramoto A. Huang N, et al. Among authors: mihara k. Blood. 1995 Jun 15;85(12):3704-12. Blood. 1995. PMID: 7780154 Free article.

5

Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis.

Kawano MM, Mihara K, Huang N, Tsujimoto T, Kuramoto A. Kawano MM, et al. Among authors: mihara k. Blood. 1995 Jan 15;85(2):487-94. Blood. 1995. PMID: 7812003 Free article.

6

A new phenotypic classification of bone marrow plasmacytosis.

Kawano MM, Mihara K, Tsujimoto T, Huang N, Kuramoto A. Kawano MM, et al. Among authors: mihara k. Int J Hematol. 1995 Jun;61(4):179-88. doi: 10.1016/0925-5710(95)00363-w. Int J Hematol. 1995. PMID: 8547606

7

Identification of early plasma cells in peripheral blood and their clinical significance.

Harada Y, Kawano MM, Huang N, Mahmoud MS, Lisukov IA, Mihara K, Tsujimoto T, Kuramoto A. Harada Y, et al. Among authors: mihara k. Br J Haematol. 1996 Jan;92(1):184-91. doi: 10.1046/j.1365-2141.1996.300835.x. Br J Haematol. 1996. PMID: 8562394

8

[Phenotypic analysis of myeloma cells].

Mihara K, Harada H, Kawano MM. Mihara K, et al. Nihon Rinsho. 1995 Mar;53(3):574-9. Nihon Rinsho. 1995. PMID: 7699888 Review. Japanese.

9

Interleukin-6 gene expression is preferentially restricted in VLA-5-MPC-1- immature but not in VLA-5+MPC-1+ mature myeloma cells.

Mihara K. Mihara K. Int J Hematol. 1996 Apr;63(3):215-26. doi: 10.1016/0925-5710(96)00439-2. Int J Hematol. 1996. PMID: 8936335

10

Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor.

Katoh O, Takahashi T, Oguri T, Kuramoto K, Mihara K, Kobayashi M, Hirata S, Watanabe H. Katoh O, et al. Among authors: mihara k. Cancer Res. 1998 Dec 1;58(23):5565-9. Cancer Res. 1998. PMID: 9850095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

650 results

Search Page

Filters